GLP-1 Receptor Agonist Use and Risk of Suicide Death.

Publication Date: 2024 Nov 01

---

Full Text Sources

Ovid Technologies, Inc.

PubMed Central (Free)

Silverchair Information Systems (Free)

Related Articles

---

Authors

Peter Ueda; Jonas Söderling; Viktor Wintzell; Henrik Svanström; Laura Pazzagli; Björn Eliasson; Mads Melbye; Anders Hviid; Björn Pasternak

---

Abstract

OBJECTIVE

Concerns have been raised regarding a link between use of glucagon-like peptide-1 (GLP-1) receptor agonists and increased risk of suicidality and self-harm.

---

Source

JAMA internal medicine

---

Pub Types(s)

Journal Article

---

Language

English

---

PubMed ID

39226030